(ROIV) – Trader Talk
-
Roivant Sciences (ROIV) to Join S&P MidCap 400; Sunrun (RUN) to Join S&P SmallCap 600
-
Guggenheim reiterates Buy rating on Tourmaline Bio (TRML), "news is likely to increase investors' perceived risk"
-
-
-
-
Back to ROIV Stock Lookup